Omeros director Schocken holds 380K shares directly

Q: What does the Form 3 filed for OMEROS CORP (OMER) by Joseph L. Schocken report?

The Form 3 reports Joseph L. Schocken’s initial beneficial ownership in OMEROS CORP common stock, including both direct holdings and indirect holdings through entities he controls, Tranceka, LLC and Tranceka Holdings, LLC.

Q: How many OMER (OMEROS CORP) shares does Joseph L. Schocken hold directly?

Joseph L. Schocken reports holding 380,472 OMEROS CORP common shares directly. This position is listed as direct ownership on the Form 3 and reflects shares held in his own name rather than through an intermediary entity.

Q: What indirect OMER (OMEROS CORP) holdings does Joseph L. Schocken report through Tranceka, LLC?

Through Tranceka, LLC, Joseph L. Schocken reports 145,100 OMEROS CORP common shares. Tranceka, LLC is wholly owned by Schocken and his spouse, and he is the sole manager, giving him beneficial ownership of these shares.

Q: What is Tranceka Holdings, LLC’s role in Joseph L. Schocken’s OMER (OMEROS CORP) ownership?

Schocken reports 2,510 OMEROS CORP common shares held indirectly through Tranceka Holdings, LLC. A footnote explains that Tranceka Holdings, LLC is wholly owned by Tranceka, LLC, which in turn is wholly owned by Schocken and his spouse.

Q: Does the Form 3 for OMER (OMEROS CORP) disclose any recent stock transactions by Joseph L. Schocken?

No specific buy or sell transactions are identified in the Form 3 data. The entries are categorized as holdings, indicating a disclosure of existing beneficial ownership positions rather than newly executed trades in OMEROS CORP stock.

OMEROS CORP (OMER) director Joseph L. Schocken filed an initial Form 3 reporting his beneficial ownership of the company’s common stock.

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

OMEROS CORP (OMER) director Joseph L. Schocken filed an initial Form 3 reporting his beneficial ownership of the company’s common stock. He reports 380,472 shares held directly, and additional indirect holdings of 145,100 shares through Tranceka, LLC and 2,510 shares through Tranceka Holdings, LLC. Tranceka, LLC is wholly owned by Schocken and his spouse and is the sole owner of Tranceka Holdings, LLC.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Schocken Joseph L

Role Director

Type	Security	Shares	Price	Value
holding	Common Stock	--	--	--
holding	Common Stock ^F1	--	--	--
holding	Common Stock ^F2	--	--	--

Holdings After Transaction: Common Stock — 380,472 shares (Direct); Common Stock — 145,100 shares (Indirect, Tranceka, LLC); Common Stock — 2,510 shares (Indirect, Tranceka Holdings, LLC)

Footnotes (2)

F1. Tranceka, LLC is wholly owned by the reporting person and his spouse, and the reporting person is the sole manager.
F2. Tranceka Holdings, LLC is wholly owned by Tranceka, LLC.

Key Figures

Direct common shares: 380,472 shares Indirect shares via Tranceka, LLC: 145,100 shares Indirect shares via Tranceka Holdings, LLC: 2,510 shares

3 metrics

Direct common shares 380,472 shares Common Stock held directly following the reported holdings

Indirect shares via Tranceka, LLC 145,100 shares Common Stock held indirectly through Tranceka, LLC

Indirect shares via Tranceka Holdings, LLC 2,510 shares Common Stock held indirectly through Tranceka Holdings, LLC

Key Terms

Form 3, beneficial ownership, indirect ownership, wholly owned

4 terms

Form 3 regulatory

"director Joseph L. Schocken filed an initial Form 3 reporting his beneficial ownership"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

beneficial ownership financial

"filed an initial Form 3 reporting his beneficial ownership of the company’s common stock"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

indirect ownership financial

"additional indirect holdings of 145,100 shares through Tranceka, LLC"

wholly owned financial

"Tranceka, LLC is wholly owned by the reporting person and his spouse"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 3 filed for OMEROS CORP (OMER) by Joseph L. Schocken report?

The Form 3 reports Joseph L. Schocken’s initial beneficial ownership in OMEROS CORP common stock, including both direct holdings and indirect holdings through entities he controls, Tranceka, LLC and Tranceka Holdings, LLC.

How many OMER (OMEROS CORP) shares does Joseph L. Schocken hold directly?

Joseph L. Schocken reports holding 380,472 OMEROS CORP common shares directly. This position is listed as direct ownership on the Form 3 and reflects shares held in his own name rather than through an intermediary entity.

What indirect OMER (OMEROS CORP) holdings does Joseph L. Schocken report through Tranceka, LLC?

Through Tranceka, LLC, Joseph L. Schocken reports 145,100 OMEROS CORP common shares. Tranceka, LLC is wholly owned by Schocken and his spouse, and he is the sole manager, giving him beneficial ownership of these shares.

What is Tranceka Holdings, LLC’s role in Joseph L. Schocken’s OMER (OMEROS CORP) ownership?

Schocken reports 2,510 OMEROS CORP common shares held indirectly through Tranceka Holdings, LLC. A footnote explains that Tranceka Holdings, LLC is wholly owned by Tranceka, LLC, which in turn is wholly owned by Schocken and his spouse.

Does the Form 3 for OMER (OMEROS CORP) disclose any recent stock transactions by Joseph L. Schocken?

No specific buy or sell transactions are identified in the Form 3 data. The entries are categorized as holdings, indicating a disclosure of existing beneficial ownership positions rather than newly executed trades in OMEROS CORP stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 08/18/2026 - 09:44 PM EDT

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Schocken Joseph L

(Last)

(First)

(Middle)

201 ELLIOTT AVENUE WEST

(Street)

SEATTLE

WASHINGTON

98119

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
08/12/2026

3. Issuer Name and Ticker or Trading Symbol
OMEROS CORP [ OMER ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	380,472	D
Common Stock	145,100	I	Tranceka, LLC⁽¹⁾
Common Stock	2,510	I	Tranceka Holdings, LLC⁽²⁾

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)

Explanation of Responses:

1. Tranceka, LLC is wholly owned by the reporting person and his spouse, and the reporting person is the sole manager.

2. Tranceka Holdings, LLC is wholly owned by Tranceka, LLC.

	/s/ Peter B. Cancelmo, Attorney-in-Fact	08/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR